Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

HollisterStier Allergy

HollisterStier Allergy?uq=PEM9b6PF
1921 FOUNDED
M&A STATUS
401-500 EMPLOYEES
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Provider of pharmaceutical products. The company's services include research, extract production, and immunotherapy product delivery with a special focus on allergen development pharmaceutical drugs that offers the best products, service, and resources for both physicians and patients.

Formerly Known As
Hollister-Stier Laboratories
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Pharmaceuticals
Parent Company
Primary Office
  • 3525 North Regal Street
  • Spokane, WA 99207
  • United States

+1 (509) 000-0000

HollisterStier Allergy Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore HollisterStier Allergy‘s full profile, request access.

Request full access to PitchBook

HollisterStier Allergy Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore HollisterStier Allergy‘s full profile, request access.

Request full access to PitchBook

HollisterStier Allergy Executive Team (1)

Name Title Board
Seat
Contact
Info
Anthony Bonanzino President & Chief Executive Officer